Few studies have prospectively examined endogenous hormone levels as risk f
actors for breast cancer, The present study compares prediagnostic hormone
levels using stored serum from breast cancer cases and controls selected fr
om the Life Span Study population of the Radiation Effects Research Foundat
ion in Hiroshima and Nagasaki, Japan. Stored serum samples collected in 196
8-1970 were assayed for 72 women subsequently diagnosed with breast cancer
and 150 control subjects in 72 case-control sets matched on age, date of bl
ood collection, exposure, radiation dose, and city, Serum levels were deter
mined for sex hormone binding globulin, total estradiol (E-2), bioavailable
E-2, dehydroepiandrosterone sulfate, and prolactin, Matched case-control c
omparisons of hormone levels were carried out by conditional logistic regre
ssion and were adjusted for menopausal status at the time of blood drawing.
The odds ratio per unit log change in bioavailable E-2 was 2.2 [95% confid
ence interval (CI), 1.02-5.3] for all subjects, and 2.3 (95% CI, 0.55-6.8)
and 2.1 (95% CI, 0.55-9.7), respectively, based only on premenopausal or po
stmenopausal serum. The estimated odds ratios in each quintile of bioavaila
ble E2 level, using the lowest quintile as referent, were 1.00, 1.89, 1.43,
3.45, and 3.37 (P for trend = 0.035), For sex hormone binding globulin, th
e overall odds ratio was 0.58 (95% CI, 0.14-2.26), and 1.00 (95% CI, 0.19-5
.45) and 0.21 (95% CI, 0.02-1.88) based on premenopausal and postmenopausal
serum, respectively, This study offers further prospective support for the
hypothesis that a high level of biologically available E-2 is a risk facto
r for the subsequent development of breast cancer.